vs
NATURES SUNSHINE PRODUCTS INC（NATR）とBRC Group Holdings, Inc.（RILY）の財務データ比較。上の社名をクリックして会社を切り替えられます
BRC Group Holdings, Inc.の直近四半期売上が大きい（$188.3M vs $123.8M、NATURES SUNSHINE PRODUCTS INCの約1.5倍）。BRC Group Holdings, Inc.の純利益率が高く（47.9% vs 3.3%、差は44.6%）。NATURES SUNSHINE PRODUCTS INCの前年同期比売上増加率が高い（4.7% vs -21.9%）。過去8四半期でNATURES SUNSHINE PRODUCTS INCの売上複合成長率が高い（5.6% vs -15.4%）
Natures Sunshine Products, Inc.（通称NSP）は、ハーブ、ビタミン、ミネラルを含む栄養補助食品やスキンケアなどのパーソナルケア製品の製造を行っています。本社はユタ州リーハイに置き、同州スパニッシュフォークに生産拠点を構えています。
NATR vs RILY — 直接比較
売上が大きい
RILY
1.5倍大きい
$123.8M
売上成長率が高い
NATR
+26.6%の差
-21.9%
純利益率が高い
RILY
純利益率が44.6%高い
3.3%
2年売上CAGRが高い
NATR
2年複合成長率
-15.4%
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $123.8M | $188.3M |
| 純利益 | $4.1M | $90.3M |
| 粗利率 | 72.5% | 79.5% |
| 営業利益率 | 4.3% | 32.3% |
| 純利益率 | 3.3% | 47.9% |
| 売上前年比 | 4.7% | -21.9% |
| 純利益前年比 | 1379.4% | 1710.8% |
| EPS（希薄化後） | $0.23 | $2.78 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上NATRRILY
| Q4 25 | $123.8M | $188.3M | ||
| Q3 25 | $128.3M | $215.3M | ||
| Q2 25 | $114.8M | $188.2M | ||
| Q1 25 | $113.2M | $197.2M | ||
| Q4 24 | $118.2M | $241.0M | ||
| Q3 24 | $114.6M | $225.5M | ||
| Q2 24 | $110.6M | $256.0M | ||
| Q1 24 | $111.0M | $263.4M |
純利益NATRRILY
| Q4 25 | $4.1M | $90.3M | ||
| Q3 25 | $5.3M | $91.1M | ||
| Q2 25 | $5.3M | $139.5M | ||
| Q1 25 | $4.7M | $-10.0M | ||
| Q4 24 | $-321.0K | $-5.6M | ||
| Q3 24 | $4.3M | $-284.4M | ||
| Q2 24 | $1.3M | $-433.6M | ||
| Q1 24 | $2.3M | $-49.2M |
粗利率NATRRILY
| Q4 25 | 72.5% | 79.5% | ||
| Q3 25 | 73.3% | 83.7% | ||
| Q2 25 | 71.7% | 81.3% | ||
| Q1 25 | 72.1% | 81.4% | ||
| Q4 24 | 72.0% | 79.8% | ||
| Q3 24 | 71.3% | 82.1% | ||
| Q2 24 | 71.4% | 84.5% | ||
| Q1 24 | 71.2% | 85.3% |
営業利益率NATRRILY
| Q4 25 | 4.3% | 32.3% | ||
| Q3 25 | 7.0% | 30.4% | ||
| Q2 25 | 3.7% | 5.7% | ||
| Q1 25 | 5.4% | -31.2% | ||
| Q4 24 | 3.8% | -69.2% | ||
| Q3 24 | 4.6% | -36.4% | ||
| Q2 24 | 5.1% | -90.8% | ||
| Q1 24 | 4.2% | -6.1% |
純利益率NATRRILY
| Q4 25 | 3.3% | 47.9% | ||
| Q3 25 | 4.2% | 42.3% | ||
| Q2 25 | 4.6% | 74.1% | ||
| Q1 25 | 4.2% | -5.1% | ||
| Q4 24 | -0.3% | -2.3% | ||
| Q3 24 | 3.8% | -126.1% | ||
| Q2 24 | 1.2% | -169.4% | ||
| Q1 24 | 2.1% | -18.7% |
EPS（希薄化後）NATRRILY
| Q4 25 | $0.23 | $2.78 | ||
| Q3 25 | $0.30 | $2.91 | ||
| Q2 25 | $0.28 | $4.50 | ||
| Q1 25 | $0.25 | $-0.39 | ||
| Q4 24 | $-0.02 | $-0.01 | ||
| Q3 24 | $0.23 | $-9.39 | ||
| Q2 24 | $0.07 | $-14.35 | ||
| Q1 24 | $0.12 | $-1.71 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $93.9M | $226.6M |
| 総負債低いほど良い | — | $1.4B |
| 株主資本純資産 | $161.6M | $-171.5M |
| 総資産 | $261.1M | $1.7B |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
現金・短期投資NATRRILY
| Q4 25 | $93.9M | $226.6M | ||
| Q3 25 | $95.6M | $184.2M | ||
| Q2 25 | $81.3M | $267.4M | ||
| Q1 25 | $86.5M | $138.3M | ||
| Q4 24 | $84.7M | $146.9M | ||
| Q3 24 | $78.7M | $159.2M | ||
| Q2 24 | $68.7M | $236.9M | ||
| Q1 24 | $77.8M | $190.7M |
総負債NATRRILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
株主資本NATRRILY
| Q4 25 | $161.6M | $-171.5M | ||
| Q3 25 | $166.7M | $-260.5M | ||
| Q2 25 | $163.7M | $-351.7M | ||
| Q1 25 | $167.1M | $-496.8M | ||
| Q4 24 | $161.0M | $-488.2M | ||
| Q3 24 | $162.6M | $-497.6M | ||
| Q2 24 | $156.4M | $-218.3M | ||
| Q1 24 | $159.7M | $228.4M |
総資産NATRRILY
| Q4 25 | $261.1M | $1.7B | ||
| Q3 25 | $264.8M | $1.7B | ||
| Q2 25 | $254.9M | $1.5B | ||
| Q1 25 | $252.7M | $1.5B | ||
| Q4 24 | $240.9M | $1.8B | ||
| Q3 24 | $245.3M | $2.2B | ||
| Q2 24 | $235.8M | $3.2B | ||
| Q1 24 | $247.3M | $5.0B |
負債/資本比率NATRRILY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $9.9M | $26.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $7.6M | — |
| FCFマージンFCF / 売上 | 6.1% | — |
| 設備投資強度設備投資 / 売上 | 1.9% | — |
| キャッシュ転換率営業CF / 純利益 | 2.41× | 0.29× |
| 直近12ヶ月FCF直近4四半期 | $28.8M | — |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローNATRRILY
| Q4 25 | $9.9M | $26.2M | ||
| Q3 25 | $18.5M | $-60.6M | ||
| Q2 25 | $4.3M | $-25.6M | ||
| Q1 25 | $2.6M | $184.0K | ||
| Q4 24 | $12.2M | $-2.7M | ||
| Q3 24 | $9.6M | $19.5M | ||
| Q2 24 | $1.3M | $111.5M | ||
| Q1 24 | $2.2M | $135.4M |
フリーキャッシュフローNATRRILY
| Q4 25 | $7.6M | — | ||
| Q3 25 | $16.8M | — | ||
| Q2 25 | $3.0M | — | ||
| Q1 25 | $1.5M | — | ||
| Q4 24 | $10.0M | — | ||
| Q3 24 | $7.9M | — | ||
| Q2 24 | $-2.0M | — | ||
| Q1 24 | $-1.5M | — |
FCFマージンNATRRILY
| Q4 25 | 6.1% | — | ||
| Q3 25 | 13.1% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 8.5% | — | ||
| Q3 24 | 6.9% | — | ||
| Q2 24 | -1.9% | — | ||
| Q1 24 | -1.4% | — |
設備投資強度NATRRILY
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 3.3% | — |
キャッシュ転換率NATRRILY
| Q4 25 | 2.41× | 0.29× | ||
| Q3 25 | 3.46× | -0.66× | ||
| Q2 25 | 0.81× | -0.18× | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
